載入...
Performance Comparison of the artus HBV QS-RGQ and the CAP/CTM HBV v2.0 Assays regarding Hepatitis B Virus DNA Quantification
BACKGROUND: Over 240 million people are chronically infected with hepatitis B virus (HBV), the leading cause of liver cancer worldwide. The quantification of the HBV DNA level is critical for monitoring the efficacy of antiviral treatment of chronic HBV patients. METHODS: In our study, we compared t...
Na minha lista:
| 發表在: | Biomed Res Int |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Hindawi
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7178467/ https://ncbi.nlm.nih.gov/pubmed/32351992 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/4159189 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|